Cognitive-Behavioral Social Skills Training: Outcome of a Randomized Controlled Trial for Youth at Risk of Psychosis
暂无分享,去创建一个
E. Granholm | Jason Holden | Lu Liu | K. Cadenhead | B. Cornblatt | Kali Brummitt | Amy Braun | J. Addington
[1] C. Hjorthøj,et al. A Systematic Review and Meta-Analysis of the Association Between Psychopathology and Social Functioning in Schizophrenia. , 2023, Schizophrenia bulletin.
[2] J. Addington,et al. Patient-Reported Outcome Measures in Clinical High Risk for Psychosis: A Systematic Review , 2023, Schizophrenia Bulletin Open.
[3] E. Granholm,et al. Cognitive-Behavioral Social Skills Training Adapted for Youth at Clinical High Risk for Psychosis. , 2022, Journal of cognitive psychotherapy.
[4] T. van Amelsvoort,et al. Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial , 2022, Psychotherapy and Psychosomatics.
[5] Chunbo Li,et al. Cognitive Behavioral Therapy for Prodromal Stage of Psychosis-Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis. , 2021, Schizophrenia bulletin.
[6] John O. Greene. Understanding Communication Performance Deficits: The Role of Ability and Motivation , 2021 .
[7] E. Granholm,et al. Cognitive behavioural social skills training: Methods of a randomized controlled trial for youth at risk of psychosis , 2021, Early intervention in psychiatry.
[8] J. Addington,et al. Progression from being at-risk to psychosis: next steps , 2020, npj Schizophrenia.
[9] M. Keshavan,et al. Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial , 2020, Schizophrenia Research.
[10] D. Roberts,et al. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial , 2020, Schizophrenia Research.
[11] J. Addington,et al. Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses. , 2020, The Journal of clinical psychiatry.
[12] I. Hickie,et al. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis , 2020, Biological Psychiatry.
[13] Tyrone D. Cannon,et al. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. , 2020, The American journal of psychiatry.
[14] J. Addington,et al. Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta‐analysis , 2019, Early intervention in psychiatry.
[15] J. Addington,et al. Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis , 2019, Current Treatment Options in Psychiatry.
[16] Tyrone D. Cannon,et al. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. , 2018, Schizophrenia bulletin.
[17] E. Granholm,et al. Cognitive‐behavioural social skills training for first‐episode psychosis: a feasibility study , 2018, Early intervention in psychiatry.
[18] Tyrone D. Cannon,et al. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis , 2018, Psychological Medicine.
[19] J. Addington,et al. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta‐analysis , 2018, Early intervention in psychiatry.
[20] D. Penn,et al. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction , 2018, Schizophrenia bulletin.
[21] Tyrone D. Cannon,et al. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis , 2017, Development and Psychopathology.
[22] Tyrone D. Cannon,et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. , 2016, The American journal of psychiatry.
[23] C. Carter,et al. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. , 2016, The American journal of psychiatry.
[24] S. Bucci,et al. What drives poor functioning in the at-risk mental state? A systematic review , 2014, Schizophrenia Research.
[25] Kristin A. Candan,et al. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[26] Lu Liu,et al. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis , 2014, Schizophrenia Research.
[27] Michael F. Green,et al. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. , 2012, Archives of general psychiatry.
[28] T. McGlashan,et al. Risk factors for psychosis: impaired social and role functioning. , 2012, Schizophrenia bulletin.
[29] P. Cuijpers,et al. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. , 2012, Schizophrenia bulletin.
[30] Peter B. Jones,et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial , 2012, BMJ : British Medical Journal.
[31] Lu Liu,et al. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis , 2011, Schizophrenia Research.
[32] T. McGlashan,et al. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up , 2010 .
[33] Paul M. Grant,et al. Asocial beliefs as predictors of asocial behavior in schizophrenia , 2010, Psychiatry Research.
[34] Paul M. Grant,et al. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. , 2009, Schizophrenia bulletin.
[35] J. Addington,et al. Using the brief core schema scales with individuals at clinical high risk of psychosis. , 2009, Behavioural and cognitive psychotherapy.
[36] Tyrone D. Cannon,et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. , 2007, Schizophrenia bulletin.
[37] W. Maier,et al. Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment , 2007, Early intervention in psychiatry.
[38] G. Dunn,et al. The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples , 2006, Psychological Medicine.
[39] N. Tarrier,et al. AN INVESTIGATION INTO THE PSYCHOMETRIC PROPERTIES OF THE COGNITIVE THERAPY SCALE FOR PSYCHOSIS (CTS-Psy) , 2001, Behavioural and Cognitive Psychotherapy.
[40] R. Mattick,et al. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. , 1998, Behaviour research and therapy.
[41] Kim T. Mueser,et al. Social Skills Training for Schizophrenia: A Step-by-Step Guide , 1997 .
[42] B. E. McDermott,et al. Development of an instrument for assessing self-efficacy in schizophrenic spectrum disorders. , 1995, Journal of clinical psychology.
[43] J. Addington,et al. Assessing Depression in Schizophrenia: The Calgary Depression Scale , 1993, British Journal of Psychiatry.
[44] W W Zung,et al. A rating instrument for anxiety disorders. , 1971, Psychosomatics.
[45] S. Woods,et al. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms , 2017, Schizophrenia bulletin.
[46] Effect of -3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders , 2016 .
[47] M. Kempton,et al. Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk , 2013 .
[48] F. Dickerson,et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. , 2010, Schizophrenia bulletin.
[49] M. First,et al. Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .
[50] M. Palmer. Clinical Trials: A Practical Approach , 1985 .